Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 4Dermatologic 2Sarcoma 1Other hematologic neoplasm 1Gastrointestinal 1Breast 1

Conditions

Gliosarcoma 31Glioblastoma 30Sarcoma 22Rhabdomyosarcoma 8Brain Neoplasms 7Astrocytoma 7Central Nervous System Neoplasms 6Melanoma 4Liposarcoma 4Histiocytoma, Malignant Fibrous 4Glioma 4Bone Neoplasms 4Sarcoma, Synovial 3Sarcoma, Ewing 3Rhabdomyosarcoma, Embryonal 3Osteosarcoma 3Neoplasm Metastasis 3Leiomyosarcoma 3Breast Neoplasms 3Rhabdomyosarcoma, Alveolar 2Prostatic Neoplasms 2Pain 2Ovarian Neoplasms 2Oligodendroglioma 2Neurofibrosarcoma 2Neoplasms 2Medulloblastoma 2Dermatofibrosarcoma 2Carcinoma, Merkel Cell 2Vulvar Neoplasms 1

Interventions

fludarabine phosphate 20Peripheral Blood Stem Cell Transplantation 19Mycophenolic Acid 17Cyclosporine 16Whole-Body Irradiation 15Cyclophosphamide 15Antilymphocyte Serum 11Busulfan 10Tacrolimus 9Methotrexate 8Radiotherapy 7Methylprednisolone 7Melphalan 6Etoposide 6Filgrastim 5Cord Blood Stem Cell Transplantation 4Polymerase Chain Reaction 3Flow Cytometry 3Amplified Fragment Length Polymorphism Analysis 3thymoglobulin 2sargramostim 2Thiotepa 2Therapeutics 2Sirolimus 2Prednisone 2Ondansetron 2Itraconazole 2In Situ Hybridization, Fluorescence 2Alemtuzumab 2tanespimycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mycosis Fungoides × Radiation × Sarcoma × Clear all
NCT02890368 2023-04-05

Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides

Pfizer

Phase 1 Terminated
56 enrolled
BreastDermatologicLymphoidSarcoma

Breast Neoplasms, Carcinoma, Squamous Cell, Melanoma, Mycosis Fungoides, Sarcoma, Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡